ZD1839 (‘Iressa’), an EGFR-selective tyrosine kinase inhibitor, enhances taxane activity in bcl-2 overexpressing, multidrug-resistant MCF-7 ADR human breast cancer cells.

CIARDIELLO F; CAPUTO R; BORRIELLO G; DEL BUFALO D; BIROCCIO A; ZUPI G; BIANCO AR; TORTORA, GIAMPAOLO

research article

oai:www.iris.unina.it:11588/167236

ZD1839 (‘Iressa’), an EGFR-selective tyrosine kinase inhibitor, enhances taxane activity in bcl-2 overexpressing, multidrug-resistant MCF-7 ADR human breast cancer cells.

Authors: CIARDIELLO F
CAPUTO R
BORRIELLO G
DEL BUFALO D
BIROCCIO A
ZUPI G
BIANCO AR
GIAMPAOLO TORTORA
Publication date: 1 January 2002
Publisher: John Wiley & Sons Incorporated:Customer Service, 111 River Street:Hoboken, NJ 07030:(800)225-5945, (201)748-6000, EMAIL: [email protected], INTERNET: http://www.wiley.com, Fax: (212)748-6551
Doi

Abstract

Abstract is not available.

info:eu-repo/semantics/article

Similar works

Full text

Archivio della ricerca - Università degli studi di Napoli Federico II

oai:www.iris.unina.it:11588/16...

Last time updated on 12/11/2016

This paper was published in Archivio della ricerca - Università degli studi di Napoli Federico II.

Having an issue?

Is data on this page outdated, violates copyrights or anything else? Report the problem now and we will take corresponding actions after reviewing your request.